Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01977703 · ClinicalTrials.gov registry record · NA

Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).

A NA study, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT01977703 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01977703, a NA study, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

We propose to study a strategy empirically applied for the past 6 months at a high volume LVAD center (Vanderbilt Heart and Vascular Institute). This utilizes an ultra conservative device programming strategy to maximize battery longevity, avoid inappropriate implantable cardioverter defibrillator (ICD) therapy, improve quality of life through reduction in overall shock burden, and potentially avoid unnecessary device generator changes prior to transplant. Avoiding CIED (cardiac implantable electronic device) change out device procedures prior to transplant is desirable.

Interventions

  • OTHER Ultra Conservative ICD Programming
  • OTHER Traditional ICD Programming

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2013-10
Est. Completion 2016-12
Phase NA

What the Registry Record Tells You About NCT01977703

The ClinicalTrials.gov registry entry for NCT01977703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ultra Conservative ICD Programming is the first listed.

NCT01977703 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01977703 about?

NCT01977703 is a clinical study titled "Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).". We propose to study a strategy empirically applied for the past 6 months at a high volume LVAD center (Vanderbilt Heart and Vascular Institute). This utilizes an ultra conservative device programming strategy to maximize battery longevity, avoid inappropriate implantable cardioverter defibrillator (...

What is the current status of trial NCT01977703?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2013-10. Estimated completion is 2016-12.

What interventions are being tested in trial NCT01977703?

The interventions under investigation include: Ultra Conservative ICD Programming (OTHER), Traditional ICD Programming (OTHER).

Who is sponsoring clinical trial NCT01977703?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.